“
“The aim of the present study was to investigate the impact of comorbid migraine on quality of life (QoL) of patients with multiple sclerosis (MS). Forty-four MS patients with comorbid migraine and 44 sex/age-matched MS subjects free from primary headache were evaluated. Although we observed that comorbid migraine did not affect the physical and mental composite scores of the MS QoL-54 questionnaire, MS patients with migraine had worse scores than those without in role limitation

due to physical problems (RL-P) (p = 0.035), bodily pain (BP) (p = 0.030) and health perception (HP) (p = 0.023) subscales. These findings were confirmed by multivariate regression CT99021 research buy analyses adjusted for demographic, clinical and psychometric variables. Significant correlations

between MIDAS score and RL-P (r = -0.43, p = 0.003), BP (r = -0.51; p < 0.001), and HP (r = -0.38; p = 0.01) were also found. In conclusion, we suggest that investigating and treating migraine in MS patients might contribute to improve their QoL.”
“Purpose: Because few treatment options exist for bisphosphonate-related osteonecrosis of the jaw (BRONJ), developing methods of early detection and prevention is vital. Computed tomography could represent a useful tool for early detection of BRONJ, yet its effectiveness Would necessitate changes in tissue density. The aim of this study was to quantify bone matrix density of tissue from patients with BRONJ.

Patients and Methods: Bone samples from 13 patients with confirmed BRONJ were Selleck MRT67307 scanned by use of high-resolution micro-computed tomography. Mean density and density distribution were assessed and compared with mandible

samples from cadaveric controls (n = 8; age range, 43-94 years).

Results: The bone matrix in BRONJ samples had a significantly higher mean density (+8.5%, P = .01) compared with cadaveric samples. The higher density PND-1186 in BRONJ tissue wits evident in it clear shift in the tissue density profile. In controls, less than 5% of the tissue had a density above the median gray-scale value, whereas on average, BRONJ tissue had approximately 15% of the tissue density in this range. By use of z score analyses of mean density values, it large degree of heterogeneity is evident among BRONJ specimens, with some samples having z scores of 0 and others having z scores well above 6 compared with controls.

Conclusions: on the basis of these findings, higher tissue density appears to manifest in only a Subset of BRONJ patients, suggesting that density may have limitations as a biomarker for early detection of this condition. (C) 2009 American Association of Oral and Maxillofacial Surgeons J Oral Maxillofac Surg 67:1373-1377, 2009″
“The last two decades have witnessed a pandemic in antibody development, with over 600 entering clinical studies and a total of 28 approved by the FDA and European Union. The incorporation of biologics in transplantation has made a significant impact on allograft survival.